The report will be delivered in 2-3 business days.

Gastrointestinal Drugs Global Market Report 2018

Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018 | SKU CODE : 3252 | Format :

The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include anti-peptic agents (antacids, antagonists, proton pump inhibitors, sucralfate, and misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant.

The top five companies covered are Takeda Pharmaceuticals, Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc and Johnson & Johnson. Takeda Pharmaceuticals was the largest company in the gastrointestinal diseases drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

Gastrointestinal Drugs Global Market Size

The global gastrointestinal drugs market was valued at above $54 billion in 2017. North America was the largest region in the gastrointestinal drugs market in 2017, accounting for above 30% market share. The USA was the largest country in the market in 2017, accounting for above 15% market share.

Gastrointestinal Drugs Global Market Trend

Drug manufacturing companies are offering tranexamic acid for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma or surgery and is now finding applications for gastrointestinal diseases. Tranexamic acid reduces clot breakdown, thus reducing the duration and amount of bleeding. This reduces mortality rate (from 10% to 7.5%) and the probability of blood transfusion by about 30%. Major companies manufacturing tranexamic acid include Abbott Laboratories, Pfizer, GlaxoSmithKline and Bayer AG.

Gastrointestinal Drugs Global Market Segmentation

The gastrointestinal drugs market is segmented into Antiulcerants, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals, and Vitamin And Minerals.
Antiulcerants segment includes drugs that are used to treat ulcers in the stomach and upper part of the small intestine. For example, Axid, Carafate, Cytotec, Pepcid, Prilosec and Tagamet.
Antacids segment includes medications that neutralize stomach acid.
Antiemetics And Antinauseants segment includes drugs that are used to treat motion sickness and are effective against vomiting and nausea. For example, Bonine, Dramamine, Emetrol and Pepto-Bismol are popular over-the-counter antiemetics in the market.
Antiobesity segment includes medications that are pharmacological agents that reduce or control weight. Orilstat, Phentermine/Topiramate ER, Lorcasarin, Naltrexone SR/Bupropion SR and Liraglutide are commonly used antiobesity drugs.
Antidiarrhoeals segment includes medications that provide symptomatic relief for diarrhea.
Vitamins & Minerals – Vitamins are organic compounds essential for nutrition and growth of the body. Minerals are inorganic substances that human body requires to function properly.

Amusement Parks Are Implementing Virtual And Augmented Reality To Increase The Customer Base
Social Media Gains Popularity As A Major Channel For Artists To Promote Their Music
Recreation Market Is Changing With An Introduction Of Booking Platforms
Mobile Ticketing For Sports Events To Provide Hassle Free Ticket Purchase Experience
Global Biologics Market, Opportunities And Strategies To 2021
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Anti-Infective Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293


+44 2071930708


+91 8897263534

(Asia & Others)